(1) The aglycon form of the steroidal sapogenin furost-5-ene-3/,22,26-triol, 3f-chacotrioside 26f-D-glucopyranoside was isolated from cell suspension cultures of Dioscorea deltoidea and its molecular structure was determined by mass spectrometry and 'H and 13C n.m.r. spectroscopy. (2) 
Steroidal sapogenins (spirostanols) e.g. diosgenin ( Fig. 1) are synthesized from cholesterol in several plants (Bennett & Heftmann, 1965; Bennett et al., 1967; Warma et al., 1969; Stohs et al., 1974; Eichenberger, 1982; Mahato et al., 1982) , but the intermediate biosynthetic steps have not yet been completely elucidated. Steroidal saponins in which the side chain is held open by glycoside formation (furostanols) are naturally occurring glycosides in several plant species (Joly et al., 1969a; Eichenberger, 1982; Sharma et al., 1982) .
These glycosides are converted in vitro to spirostanols by the elimination of the glucose molecule at C-26 and ring closure by the action of glucosidases (see Fig. 1 for the formation of an analogous compound, asparanin D) (Marker & Lopez, 1947; Schreiber & Ripperger, 1966; Ripperger et al., 1967; Tschesche et al., 1967 Tschesche et al., , 1972 Eichenberger, 1982; Sharma et al., 1982) . Radioactively labelled furost-5-ene-3fi, 22,26-triol 3fi-chacotrioside 26fl-D- leaf homogenates of Dioscorea floribunda (Joly et al., 1969a) . These results suggest that the biosynthesis of diosgenin from cholesterol proceeds via furostanol I, similar to the proposed biosynthetic pathways of other spirostanols from their corresponding furostanols in various plants (Eichenberger, 1982; Sharma et al., 1982) .
We present data supporting the hypothesis that furostanol I is an intermediate in vivo for diosgenin.
Materials and methods

Growth conditions
Dioscorea deltoidea cells were grown in 100 ml of Murashige & Skoog (1962) medium supplemented with 2,4-dichlorophenoxyacetic acid (0.1 mg/l). Growth of cells in suspension cultures was described previously . Isolation of diosgenin and the putative steroidal intermediate
The fractionation of steroidal sapogenins from D. deltoidea was previously described (Tal & Goldberg, 1981) . Diosgenin and the putative intermediate were separated by h.p.l.c. and fractions containing these compounds were collected (Tal & Goldberg, 1981 Fig. 2 . A maximal amount of biomass (6.5g of cell dry wt./l; cellular yield 0.43 g ofcell dry wt./g of sucrose utilized) was obtained 10 days after inoculation followed by a pronounced reduction in cell dry weight. Diosgenin synthesis started 5 days after inoculation and reached a level of 184mg/l (7.25% of dry weight) after 29 days. The relative amount of the steroidal compound was calculated from the peak area of this compound in the h.p.l.c. chromatogram (see Fig. 3 ). During the course of analysis of cell extracts, an unidentified steroidal compound (see below) was detected in the h.p.l.c. chromatograms (Fig. 3a) . The peak area of this compound was greater in extracts obtained from 8-day-old cultures than in 3-day-old cultures, and decreased to a negligible level in 20-day-old suspension cultures (Fig. 3b) . Detailed kinetics showed (Fig. 2) that the accumulation of the steroidal compound (putative intermediate) proceeded in parallel with cell growth and, after the amount of biomass reached a maximum, the level of this compound decreased rapidly (5% of its maximal level). The results suggested that a precursor-product relationship exists between the steroidal compound and diosgenin.
Isolation and characterization of the steroidal compound
The steroidal compound had a retention time of 1.25 min when applied on a reversed-phase h.p.l.c. column. Diosgenin had a retention time of 6 min ( Fig. 3a) . This suggested that the steroidal compound is more polar than diosgenin.
The mass spectrum of the purified compound contained signals of m/z 414 (MI), 398, 355, 342, 327, 300, 282, 271 IH and 13C n.m.r. spectroscopies were used to verify the molecular structure of the purified steroid. The assignments of the signals of this compound in the spectra were obtained by com- , 1981) . The methylenic envelopes in both spectra were very similar and they differed only by a single peak at 6 2.18 having an intensity corresponding to two protons in the spectrum of the steroidal compound. This peak is probably best rationalized as two hydroxyl groups at C-22 and C-26.
Diosgenin and the steroidal compound were acetylated in an effort to account for the number of Vol. 219 hydroxyl groups in the molecules. The spectrum of acetylated diosgenin indicated the presence of a single acetoxy group at 2.03 due to the acetylation ofthe C-3 hydroxyl. The spectrum of the acetylated steroid compound consisted of many peaks as a result of the acetylation procedure, indicating that the compound was not stable under these conditions. The results of the IH n.m.r. analysis suggested that the steroidal compound is the aglycon form of furost-5-ene-3p,22,26-triol 3fl-chacotrioside 26#-Dglucopyranoside (furostanol I) and its proposed molecular structure is shown in Fig. 1 .
The 13C n.m.r. spectra were determined in order to confirm the proposed molecular structure of the steroidal compound in comparison with that of diosgenin. The corresponding chemical shifts and their assignments (Tori et al., 1981; Espejo et al., 1982) Diosgenin and the steroidal sapogenin were labelled with [1-14C]acetate in short-time feeding experiments (6h) and the specific radioactivities were determined ( Table 2 ). The specific radioactivity of diosgenin decreased by about 5-fold from day 2 to day 6 when maximal growth was obtained. After the growth phase the specific radioactivity of diosgenin was further decreased by about 350-fold, 16 days after inoculation. Since the total amount of diosgenin increased 23-fold from day 2 to day 16 (Table 2) , the decrease in the rate of acetate incorporation into diosgenin suggests that most of the diosgenin is not synthesized directly from acetate in vivo but rather from an intermediate precursor(s).
The specific radioactivity of the steroidal compound increased slightly from day 2 to day 4 and then decreased. The level of this steroid increased up to day 9 and then decreased to about 5% of its maximal level (Table 2 ). This would indicate that the rate of synthesis of this compound from acetate was maximal in the early stages of exponential growth. During the later stage of growth (day 6 and day 9) the rate decreased without a parallel decrease in the amount of this compound, suggesting a transient accumulation of the steroidal metabolite before it was further metabolized to diosgenin.
In a pulse-chase experiment (Table 3) the total radioactivity incorporated into diosgenin during the pulse increased during the chase period, while the radioactivity in the steroidal compound decreased. The increase of total radioactivity in diosgenin corresponded to the decrease in the radioactivity incorporated into the steroidal compound, and strongly suggested that the latter sapogenin is a direct intermediate precursor of diosgenin (Table 3) .
Discussion
The synthesis of the steroidal sapogenin diosgenin is not associated with active cell growth and occurred mainly in non-dividing cells of Dioscorea deltoidea suspension cultures (Stohs et al., 1974; . Our working hypothesis was that a precursor is formed de novo from acetate during the exponential growth phase, and biotransformed to diosgenin mostly after growth ceased. In order to identify the possible precursor in vivo of diosgenin the sterols of D. deltoidea cells were analysed. The analysis revealed the presence of a steroidal compound in the h.p.l.c. chromatogram (Fig. 2a) . A detailed study of the time course production of diosgenin and the steroidal compound ( Fig. 1) indicated that the latter may be an intermediary metabolite in the biosynthetic pathway of diosgenin. On the basis of spectroscopic investigations (mass spectrometry and 1H and 13C n.m.r.) it was possible to establish the structure of the putative intermediate as the aglycon form of the steroidal sapogenin furost-5-ene-3,B,22,26-triol 3fB-chacotrioside 26fB-D-glucopyranoside (furostanol I; Fig. 1 ).
Labelled furostanol I was prepared by treatment of Dioscorea floribunda plants with [4-14C] cholesterol (Joly et al., 1969b) . It was shown that furostanol I was completely converted to dioscin (the glycoside form of diosgenin) by a leaf homogenate of that species ( Fig. 1; see Joly et al., 1969a) . These results led to the conclusion that the biosynthesis of dioscin (or diosgenin) from cholesterol proceeds via furostanol I in D.floribunda (Joly et al., 1969a) . Similar studies (Marker & Lopez, 1947; Schreiber & Ripperger, 1966; Ripperger et al., 1967; Tschesche et al., 1967 Tschesche et al., , 1972 Eichenberger, 1982; Sharma et al., 1982) have demonstrated that different furostanols, isolated from various plants, were converted in vitro to the corresponding spirostanols by treatment with fJglucosidases (for example, the conversion of asparoside D to asparanin D shown in Fig. 1 ).
These studies did not show that furostanol I was a precursor in vivo of diosgenin nor when it or diosgenin were synthesized.
The results of the pulse-chase incorporation study of [1-14C] acetate into sterols of D. deltoidea cells (Table 3) presented strong evidence for the biosynthesis of dioscin from a furostanol in which the F-ring is held open by glucosidation at the C-26 hydroxyl (furostanol I). These results also supported the theory (Joly et al., 1969b; Stohs et al., 1969 Stohs et al., , 1974 Bennett et al., 1970 ) that in sapogenin biosynthesis oxygenation occurs first at C-26 followed by cyclization of the sterol sidechain. Upon extraction and hydrolysis (see the Materials and methods section) dioscin and furostanol I were obtained as diosgenin and the steroidal compound, respectively. We have previously argued that the improvement of diosgenin biosynthesis (preferably in a continuous process) is a major factor in the possible utilization of D. deltoidea cells for the industrial production of this useful compound (Tal et al., 1983) . As the synthesis of diosgenin is not associated with active cell growth, a two-stage continuous process was required with growth in stage I and biotransformation to diosgenin in stage II to obtain appreciable production rates of diosgenin (Tal et al., 1983) . The results of the present study, showing that furostanol I is accumulated during growth of D. deltoidea cells in suspension cultures, suggest another possible scheme for the efficient production of diosgenin.
Growing cells could be harvested continuously from a chemostat and the steroidal precursor (the aglycon of furostanol I) prepared. The addition of P-glucosidase to purified precursor should transform it to diosgenin. The feasibility and economics of this scheme are being studied.
